Posts for the 'Fentanyl' Category
FDA concerned about Fentora problems with wider use
Cephalon, Inc. is attempting to seek FDA approval for Fentora tablets to be used for sudden pain in non-cancer patients who have already developed a tolerance to opioids. An FDA advisory panel is scheduled to meet on Tuesday to review the subject. Documents released in advance of the meeting indicate that the FDA is concerned that wider approval could have a “devastating effect” due to the risk of Fentora overdose and abuse.
Duragesic and Fentanyl Patch lawsuits investigated for users of recalled patches
For the third time in less than a month, a fentanyl patch recall has been issued due to fears that manufacturing defects could allow the powerful medication contained in the patch to leak directly onto the skin. This could cause respiratory depression, a fentanyl overdose or death. Millions of potentially defective patches have now been recalled and the lawyers at Saiontz, Kirk & Miles, P.A. are reviewing potential Duragesic and Fentanyl Patch lawsuits for users who have experienced a severe injury or death as a result of an overdose.
>>INFORMATION: Fentanyl Patch Lawsuits
Second Fentanyl Patch Recall issued
Two fentanyl patch recalls have been issued over the past seven days due to a risk that users or handlers of the powerful painkiller could experience respiratory depression or fentanyl overdose after coming into contact with the patch. Two different manufacturing defects at different plants have resulted in recalls involving the brand name Duragesic pain patch and generic fentanyl patches sold by Sandoz and Actavis. The fentanyl gel in these patches could leak out and come into direct contact with the skin, resulting in serious and potentially fatal injuries.
>>PRIOR POST (2/13/2008): Duragesic Pain Patch Recall
Duragesic recall issued due to leaking fentanyl gel
Yesterday, Johnson & Johnson issued a Duragesic recall for all lots of their 25 microgram-per-hour fentanyl patches. Some of the powerful painkilling patches could contain a cut in the lining of the internal reservoir where the fentanyl gel is stored. This may allow the gel to leak directly onto the skin, resulting in serious and potentially fatal problems, such as respiratory depression or a possible fentanyl overdose.
>>INFORMATION: Duragesic Recall Lawsuits
Duragesic patch dangers continue to cause overdose and death
Last month the FDA issued a second warning about Duragesic patch dangers which have claimed the lives of many people who never should have been given the powerful narcotic painkiller. Despite knowledge of these risks, Johnson & Johnson, the manufacturer of the Duragesic patch, continues to fail to take steps which could reduce the risk of injury and ensure that doctors and patients are aware of the problems associated with their pain patches.
>>INFORMATION: Duragesic patch lawsuits
Fentanyl patch problems lead to second FDA warning
The FDA has issued a second warning about problems associated with the fentanyl pain patch. The powerful drug, which has been on the market since 1990, continues to result in unnecessary overdoses and deaths, especially when it is used inappropriately. Despite an earlier warning issued over two years ago, fentanyl patch problems claim lives and many doctors still do not appreciate the dangers associated with the drug.
>>INFORMATION: Fentanyl patch overdose and death
Fentora lawsuits are reviewed as FDA issues warning
The FDA issued a public health notice yesterday about the risk of death associated with the use of Fentora tablets. Side effects could result in overdose or death caused by inappropriate use and over-prescription. The manufacturer, Cephalon, Inc., has agreed to add stronger warnings and improve the dosing instructions to reduce the risk of problems. The lawyers at Saiontz, Kirk & Miles, P.A. are reviewing potential Fentora lawsuits for deaths caused by overdose after using the drug.
>>INFORMATION: Fentora lawsuits
Fentanyl overdose deaths linked to off-label use of Fentora
According to warnings posted yesterday by the FDA, Fentora has been linked to several deaths caused by fentanyl overdose. Fentora is a newer medication, similar to the Actiq lollipop, which is only approved for use in cancer patients who have breakthrough pain not managed by other medications. The manufacturer of Actiq and Fentora, Cephalon, Inc., is currently being investigated for improper marketing practices which encouraged widespread off-label use of their powerful drugs for conditions such as headaches and back pain.
>>INFORMATION: Fentanyl death and overdose
Reducing the danger of fentanyl patch overdose
Concerned by reports of fentanyl patch overdoses and deaths, the Institute of Safe Medicine Practices issued recommendations to reduce the dangers of fentanyl patch problems. Misinformed and careless physicians continue to prescribe the pain patch inappropriately, with doses that are too large or in combination with other opiates which could result in a serious and potentially fatal overdose of fentanyl.
>>INFORMATION: Dangers of Fentanyl Patch
Duragesic fentanyl skin patch dangers still underestimated
According to an article in the Los Angeles Times, the degree of danger associated with the Duragesic fentanyl skin patch is still not fully appreciated by healthcare providers and deaths continue to occur at an alarming rate as a result of sudden fentanyl overdose for unsuspecting users.
>>INFORMATION: Duragesic fentanyl skin patch overdose
